Infect Immun, April 1998, p. 1570-1578, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
University Department of Paediatric
Gastroenterology,
Received 8 October 1997/Returned for modification 13 November
1997/Accepted 22 January 1998
Attaching and effacing (A/E) lesion formation is central to
enteropathogenic Escherichia coli (EPEC) pathogenesis.
In vitro experiments with human epithelial cell lines have implicated
virulence plasmid-encoded bundle-forming pili (BFP) in initial
binding and intimin in intimate attachment and A/E lesion formation.
This study investigated the role of BFP and intimin in EPEC
interactions with pediatric small intestinal biopsy tissue in in vitro
organ culture. Organ culture infections (2 to 8 h) were performed
with E2348/69 (a wild-type EPEC O127:H6 clinical isolate) and
E2348/69 derivatives including CVD206 (eae deficient),
CVD206(pCVD438) (eae-complemented CVD206),
CVD206(pCVD438/01) (expressing intimin, which is nonfunctional due
to a single amino acid substitution), JPN15 (spontaneous EPEC
adherence factor virulence plasmid-cured E2348/69), and 31-6-1(1)
(E2348/69 with a TnphoA insertion inactivation mutation in
the virulence plasmid-encoded bfpA gene). Scanning and
transmission electron microscopy revealed that after 8 h E2348/69 and CVD206(pCVD438) (both Int+ BFP+)
adhered to all specimens, causing A/E lesions with surrounding microvillous elongation. JPN15 and 31-6-1(1) (both Int+
BFP Enteropathogenic Escherichia
coli (EPEC) is an important cause of severe diarrhea in developing
countries, particularly among young infants (4, 17, 36).
Proximal small intestinal biopsies taken from EPEC-infected children
show bacteria adherent to the mucosal surface in discrete, localized
colonies. Electron microscopic examination reveals bacteria adherent to
cup-like pedestals with effacement of microvilli (44, 48),
constituting what is known as the attaching and effacing (A/E) lesion
(41), which is central to EPEC pathogenesis.
Observations from experiments using cultured human epithelial cell
lines have implicated several genes and their protein products in A/E
lesion formation, and a three-stage model of EPEC infection has been
suggested (6). The first stage of the infection involves initial, nonintimate attachment of the bacillus to the enterocyte cell
surface via bundle-forming pili (BFP) (16) encoded by the bfp gene cluster (46, 47) on the 60- to 70-kDa
EPEC adherence factor (EAF) plasmid (1). The second stage of
the infection is thought to involve a type III secretion apparatus that
mediates the secretion of EPEC-secreted proteins (22). These
proteins are implicated in triggering a host cell signal transduction
cascade (10, 27) resulting in cytoskeletal component
rearrangement and microvillous elongation and vesiculation
(42). Recent data have provided evidence that EPEC transfers
a protein into the host cell which is then phosphorylated and inserted
in the membrane to create a cell surface binding epitope for intimin (a
94-kDa outer membrane adhesin encoded by the chromosomal eae
gene [24]). The protein has been called the
translocated intimin receptor or Tir (26). It was previously
referred to as Hp90 and was thought to be of host cell origin
(43). The third stage of infection according to this model
is characterized by intimin-mediated intimate attachment and
accumulation of polymerized actin in pedestals at sites of intimate
bacterial attachment (24), a process which is also thought
to be triggered by Tir (26). Deletion of the eae
gene has been shown to reduce EPEC pathogenicity in human volunteer
challenge studies (8). Experiments have shown that eae deletion mutants can adhere to cultured epithelial cells
but do not adhere intimately or form A/E lesions (5).
Conversely, Knutton et al. (30) showed that a wild-type EPEC
strain spontaneously cured of the EAF plasmid, and therefore deficient
in BFP expression, was still able to adhere to cultured adult
intestinal mucosa in small microcolonies (although in reduced numbers)
and form A/E lesions, suggesting that the plasmid is not required for
later-stage A/E lesion formation. All the genes necessary for the
second and third stages of A/E lesion formation are reported to be
contained within a 35-kbp chromosomal pathogenicity island called the
locus of enterocyte effacement region (39, 40).
Plasmid-encoded regulatory genes (per genes) have been
described which activate intimin expression (18). More
recently, EPEC per genes have been shown to down-regulate
intimin expression following A/E lesion formation (35).
In vitro organ culture (IVOC) with human intestinal tissue has been
used to study EPEC pathogenesis (20, 30). Using this as a
more appropriate model of the in vivo environment, Knutton and
colleagues (30) showed that EPEC isolated from cases of infant diarrhea was able to form A/E lesions on adult duodenal mucosa
which were indistinguishable from A/E lesions seen in vivo. EPEC
pathogenesis was studied further in this work, and this report questions the role of BFP in initial nonintimate attachment to the
mucosa and emphasizes the importance of intimin in establishing colonization of pediatric small intestinal tissue.
(Preliminary findings have been published previously in abstract form
[21].)
Bacterial strains.
The bacterial strains examined in
this study were E2348/69 (a wild-type EPEC) (37) and five
E2348/69 derivatives: CVD206 (5), CVD206(pCVD438)
(24), CVD206(pCVD438/01) (11), JPN15 (23), and 31-6-1(1) (7). A summary of the strain
characteristics is shown in Table 1.
CVD206(pCVD438/01) (11) was included because although
intimin is biologically inactive in this strain it is still inserted
into the outer membrane and therefore there should be less disruption
of the constitution of the outer membrane. All bacterial strains were
stored routinely at
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
) adhered and caused A/E lesions although bacteria
adhered in "flat," two-dimensional groups. CVD206 and
CVD206(pCVD438/01) (both Int
BFP+) did
not adhere to any sample, and no pathological tissue changes were seen.
Thus, in human intestinal organ culture, BFP do not appear to be
involved in the initial stages of EPEC nonintimate adhesion but are
implicated in the formation of complex, three-dimensional colonies via
bacterium-bacterium interactions. Intimin appears to play an essential
role in establishing colonization of EPEC on pediatric small intestinal
tissue.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
70°C in a Microbank system (Prolab Diagnostics,
Neston, England). Prior to adhesion studies, bacterial strains were
subcultured into brain heart infusion broth (containing chloramphenicol
at a concentration of 12 µg/ml or kanamycin at a concentration of 20 µg/ml where appropriate) and incubated aerobically overnight at
37°C without agitation.
TABLE 1.
Bacterial strains
Immunostaining of HEp-2 cell-adherent EPEC. To ensure that the EPEC strains were capable of expressing the appropriate surface antigens HEp-2 cell-adherent bacteria were examined by the following immunostaining techniques. A standard 3-h HEp-2 cell assay was performed (3) with cells grown overnight on 13-mm-diameter glass coverslips to a confluency of approximately 80%. After incubation with the bacterial strains, cells were washed thoroughly five times with sterile phosphate-buffered saline (PBS) and fixed with 4% buffered formalin for 90 min. After repeated washing with PBS, cells and adherent bacteria were incubated at room temperature for 30 min with nonimmune swine serum (diluted 1:10 in PBS) to block nonspecific binding sites. Cells were stained for 1 h with a rabbit polyclonal antibody raised against the cell binding domain of intimin from an O127:H6 isolate (35) (1:100) or with a polyclonal antibody raised against the bundlin subunit of BFP (1:500) (kindly donated by Jorge Girón). Negative controls included the omission of either primary antibody and the use of an unrelated polyclonal (anti-O114) antibody. Anti-E. coli antibody (Dako Ltd, High Wycombe, United Kingdom) was used as a positive control. Goat anti-rabbit immunoglobulin G-fluorescein isothiocyanate (1:100) was used, for 1 h at room temperature, as the secondary antibody. All coverslips were mounted by using Citifluor fluorescence mounting medium (Agar Scientific Ltd, Stansted, United Kingdom) and were stored in the dark at 4°C until being viewed with a Zeiss Universal microscope with appropriate fluorescein isothiocyanate filters.
FAS test. Each of the six EPEC strains was examined by using the fluorescent-actin staining (FAS) test. This test was performed by the method described by Knutton and colleagues (31).
SEM of HEp-2 cell-adherent EPEC. To control for the effects of bacterial growth conditions and scanning electron microscopy (SEM) processing, E2348/69 and CVD206 were cultured overnight as described above and incubated with HEp-2 cells (grown on 13-mm-diameter coverslips also as described above) for 1, 2, 3, and 6 h. At the end of the incubation the coverslips were washed thoroughly three times in sterile PBS and processed routinely for SEM.
Tissue samples. Tissue samples were obtained from 14 children, with fully informed parental consent and ethical approval, from the distal duodenum or duodeno-jejunal junction with either a double-port pediatric Crosby capsule (28) or a grasp biopsy forceps during routine endoscopic (Olympus PCF pediatric endoscope) investigation of intestinal disorders. Terminal ileal tissue was taken from seven patients by the grasp biopsy method from areas showing no endoscopic abnormality or from the ileal margin of surgically resected tissue showing no disease involvement (one patient). The age range of patients (19 males and 3 females) was between 12 and 190 months (median, 102 months). All intestinal histologies were reported to be normal.
Organ culture adhesion assay. IVOC was performed as described previously (20). The assay was terminated at 2 and 4 h on three occasions to determine "early" events. "Later" events were observed at 6 h on two occasions, and all other experiments were maintained for 8 h. Tissue culture medium was changed every 2 h, although these changes were not complete as some medium plus bacterial inoculum would remain within the foam insert supporting the tissue sample and in association with the tissue by surface tension. Each bacterial strain was examined in IVOC on at least three occasions with tissue from different children. Strain E2348/69 and an uninoculated specimen were included with each experimental culture to act as appropriate positive and negative controls, respectively.
Tissue processing. After the culture period specimens were washed thoroughly three times to remove any nonadherent bacteria and then prepared for SEM as described previously (20). Following fixation and dehydration, specimens were placed in 100% ethanol and critical point dried in liquid CO2 with an Emitech K850 critical point drying apparatus. Samples were then mounted on aluminium stubs and sputter coated with gold-palladium by using a Polaron sputter coating apparatus. Specimens were observed with a JEOL JSM-5300 SEM at an accelerating voltage of 30 kV. For transmission electron microscopy (TEM) postfixed specimens were dehydrated in 2,2-dimethoxypropane with three changes over 9 min and embedded in TAAB resin (TAAB Laboratories, Reading, United Kingdom). Ultrathin sections (0.1 µm) were double stained with 2% uranyl acetate and lead citrate and examined in a JEOL JEM 1200-EX II TEM at an accelerating voltage of 80 kV.
| |
RESULTS |
|---|
|
|
|---|
Immunostaining of HEp-2 cell-adherent EPEC. Prior to infection of IVOC we confirmed, by indirect immunofluorescence staining, that the E2348/69 derivatives were capable of expressing intimin and/or BFP. All six strains adhered to HEp-2 cells. Results from negative and positive controls were as expected: no fluorescing bacteria were seen on any coverslip stained either with anti-O114 or with the primary antibody stage omitted despite many bacteria being observed by light microscopy. All six EPEC strains were strongly fluorescent with anti-E. coli sera. Localized colonies were formed by E2348/69 and CVD206(pCVD438); small clusters of adhering bacteria were seen with strains 31-6-1(1), JPN15, CVD206, and CVD206(pCVD438/01). EPEC E2348/69 reacted positively with anti-intimin and with anti-BFP; a smooth fluorescent pattern was noted around bacteria stained with anti-intimin (Fig. 1a) and a more spiky pattern was noted around bacteria stained with anti-BFP (Fig. 1b). Similar staining patterns were noted with CVD206(pCVD438) (data not shown) and CVD206(pCVD438/01); the latter strain was positive for the anti-intimin antibody (Fig. 1c) despite expressing an inactive intimin molecule. EAF plasmid-cured strain JPN15 (data not shown) and bfpA-mutated 31-6-1(1) (Fig. 1d) reacted positively with anti-intimin but not with anti-BFP. EPEC CVD206 showed no fluorescing bacteria when stained with anti-intimin but had a positive fluorescing pattern with anti-BFP (Fig. 1e).
|
SEM of adhesion of EPEC E2468/69 and derivative CVD206 to HEp-2 cells. Bacteria were identified adhering to the cells at all time points. E2348/69 showed A/E lesion formation at 2 to 3 h and completely covered the cells at 6 h (data not shown). CVD206 did not show A/E lesion formation, and there was an increase in the number of adhering bacteria from 1 to 3 h (Fig. 2A) and a decrease at 6 h.
|
Adhesion of EPEC E2348/69 and Int+ BFP+
and Int
BFP+ derivatives to cultured
pediatric small intestinal mucosa.
At all time points uninoculated
IVOC specimens appeared morphologically normal. These showed good
preservation of villous architecture, an intact epithelial surface
without loss of the glycocalyx, and no evidence of excess extrusion of
enterocytes or mucus (Fig. 2B). No adherent bacteria were noted on the
surface of these specimens.
BFP+) did not adhere to any
sample, and no pathological tissue changes were seen (Fig. 2E).
However, specimens incubated with intimin-reconstituted strain
CVD206(pCVD438) (Int+ BFP+) had an
appearance similar to that of specimens incubated with E2348/69 in
that bacteria adhered to the small intestinal mucosa in localized
groups causing A/E lesion formation (Fig. 2F). Strain CVD206(pCVD438/01), expressing an inactive surface intimin
(Int
BFP+), did not adhere to any sample and
no pathological tissue changes were seen (Fig. 2G).
Despite evidence that CVD206 was able to adhere to HEp-2 cells in
vitro (Fig. 2A) in the absence of intimin (5), there was no
observed adhesion to pediatric small intestinal tissue after 8 h
of culture. In order to determine whether early adhesion may occur with
subsequent detachment of bacteria, further IVOC incubations were
performed with 2- and 4-h end points. After 2 h of culture with
each of the six EPEC strains there appeared to be a slight increase in
rounded and extruding cells. However, no adherent bacteria or
pathological damage was seen, except in one of the three incubations
with E2348/69, where several individual adherent bacteria were seen
in association with minor microvillous elongation (Fig.
3A). No other strain was observed to
adhere. After 4 h in organ culture strains E2348/69 and
CVD206(pCVD438) consistently showed small localized colonies
associated with microvillous elongation in all experiments (Fig. 3B),
while CVD206 and CVD206(pCVD438/01) did not adhere to any specimen.
|
Adhesion of EPEC derivatives (Int+ BFP
)
to cultured pediatric small intestinal mucosa.
As no bacterial
adhesion was seen with Int
BFP+ strains
questions were raised as to the role of BFP in initial adhesion. After 6 to 8 h in organ culture two BFP-deficient strains, plasmid-cured JPN15 and TnphoA-mutated 31-6-1(1) (both Int+
BFP
), adhered to all specimens and caused microvillous
elongation with A/E lesion formation (Fig.
4A and B, respectively, and confirmed by
TEM [data not shown]), although smaller numbers of bacteria were seen
and microvilli were not as elongated as with E2348/69. Bacterial
groups were more "two dimensional," i.e., bacteria adhered in a
single layer with spaces between them (Fig. 4A) rather than in the
tight localized adhering (LA) clusters seen with E2348/69 and
CVD206(pCVD438). Early events were again studied. After 2 h in
IVOC no bacterial adhesion or pathological changes were noted. However,
after 4 h, on two of three occasions, JPN15 formed small flat
groups and 31-6-1(1) adhered as single bacteria, and all were
associated with minor microvillous elongation (Fig. 4C) which was less
exaggerated than at later time points.
|
| |
DISCUSSION |
|---|
|
|
|---|
Experiments using human epithelial cells in culture and molecular biological manipulation of EPEC strains have given major insights into the pathogenetic mechanisms of these organisms (4, 6, 29, 31, 38). However, although HEp-2 cells, one of the more widely used in vitro models for studying E. coli pathogens, are easy to handle and manipulate, these cells are nonpolarized carcinoma cells derived from a nonintestinal source which have been maintained in continuous culture for many years. Here, we have demonstrated that EPEC strains interact differently with freshly harvested intestinal tissue from children, the age group most affected by these bacterial pathogens, than with cell lines in culture. IVOC has been well validated as a model for the study of E. coli pathogenesis including that of EPEC (30), enterotoxigenic E. coli (32), and enteroaggregative E. coli (20, 34).
EPEC strains expressing biologically active intimin, with or without
BFP, were able to adhere to the small intestinal mucosal surface and
cause A/E lesions indistinguishable from those seen in vivo. The strain
CVD206, which lacks the eae gene and therefore did not
express intimin but does possess BFP, did not adhere in IVOC.
Complementation of CVD206 with the eae gene restored the surface expression of intimin (35) and resulted in adhesion and A/E lesion formation in IVOC. In addition, a strain in which a
single amino acid substitution (Cys397
Ala) in the cell
domain (12) abrogated intimin biological activity but did
not prevent its surface expression showed no adhesion to human
intestinal tissue in vitro and no pathological alterations were
detected. This suggests that the ability of EPEC to form
intimin-mediated intimate contact with the human intestinal mucosa is
central to intestinal colonization.
According to the three-stage model of EPEC pathogenesis (6), it is thought that BFP are important for the initial attachment of EPEC to the host cell surface. However, Knutton et al. (30) showed that the plasmid-cured EPEC strain JPN15 was still able to adhere to human intestinal mucosa and cause A/E lesion formation, albeit less efficiently than wild-type EPEC E2348/69. Incubating JPN15 with pediatric IVOC confirmed the report of Knutton et al. (30) and showed A/E lesion formation, although there was less adhesion than with E2348/69 (in terms of the number of adhering organisms). However, it was also observed that bacteria were spaced further apart and that colonies appeared two, rather than three, dimensional, suggesting that plasmid-borne genes were involved in the formation of interbacterial links in the LA colony, allowing it to rise above the mucosal surface. The same appearance of flat, two-dimensional LA colonies with A/E lesion formation was seen when strain 31-6-1(1) (7) was used. In this strain a single gene, bfpA, has been mutated, which disrupts BFP production but leaves the rest of the EAF plasmid intact. This indicates that it is BFP which are responsible for complex three-dimensional colony formation, presumably via bacterium-bacterium interconnections. Steric effects of BFP binding may contribute to the three-dimensional appearance.
Thus, the evidence from pediatric intestinal IVOC suggests that BFP are not involved in the initial attachment of EPEC to the mucosal surface but that these fimbrial structures enhance three-dimensional microcolony formation after intimate attachment and A/E lesion formation have been achieved.
Although BFP-negative strains of eae-positive E. coli are isolated from cases of diarrheal disease (2, 33), there is some debate about the true pathogenic significance of such strains (25). The observations that EAF probe-negative E. coli strains isolated from pediatric cases of acute diarrheal disease are able to cause A/E lesions on adult intestinal tissue in vitro (33) and that O119 serogroup E. coli, strains, which do not express BFP and are EAF probe negative, are bfpA gene probe positive (19), indicating they have not simply lost the plasmid during passage through the gut, support the idea that these strains have a role in diarrhea. However, despite the results of case-controlled epidemiological studies in Chile (38) and Thailand (9) which did not find higher rates of isolation of such strains in children with diarrhea than in children without diarrhea, these strains have been identified in diarrheal cases where no other pathogens were detected (45) and an EAF-negative, eae-positive strain has been implicated in a diarrheal outbreak (49).
Based on our results we propose a modification to the three-stage model of EPEC infection (6) (Fig. 5). Stage 1 involves the nonintimate adhesion to the host cell surface via an adhesin(s) other than BFP. This leads to stage 2 in which cellular signal transduction events mediated by EPEC-secreted proteins induce cytoskeletal disruption and produce stage 3. Stage 3 involves intimate attachment to the enterocyte surface via intimin, producing A/E lesion formation. Typical EPEC strains expressing BFP proceed to stage 4, which involves three-dimensional expansion of the microcolony. The microcolonies are maintained and stabilized by BFP which connect bacteria to one another. Interbacterial connections mediated by BFP, in the absence of intimate mucosal adherence, may allow detachment and colonization of other mucosal sites, possibly contributing to the spread of infection along the gut. Atypical EPEC strains, lacking BFP expression, would not proceed to stage 4.
|
The fact that at early time points of observation individual bacteria or small groups are seen adhering to the mucosal surface suggests that EPEC microcolonies form from adhering bacteria multiplying in situ or from recruitment of individual bacteria from the surrounding medium and not that LA groups are ready formed in the bacterial culture prior to organ culture assay and act as infectious units (50).
Another factor which may be relevant to the differences observed between adhesion to HEp-2 cells in culture and to human intestinal tissue in IVOC is the difference in the apical membranes. Recently it has been shown that the presence of a thick glycocalyx coating the surface of intact intestinal epithelial tissue can act as a barrier to bacterial adhesion (14). This layer is not present on HEp-2 cells, and there is a much more complex microvillous brush border on intestinal epithelium. In these respects the two model systems are quite distinct and different and/or additional virulence factors may be required in the in vivo situation.
All strains used in this study adhered to HEp-2 cells. The importance of Cys937 for intimin activity (13) was confirmed because, although surface expression of intimin by strain CVD206(pCVD438/01) adhering to HEp-2 cells was demonstrated by immunofluorescence, no A/E lesion was detected by the FAS test. Although our findings indicate that BFP do not appear to be involved in the initial stages of adhesion of EPEC to intestinal mucosa in organ culture, there is evidence that BFP mediate the adhesion of EPEC to HEp-2 cells. Adhesion can be blocked by a polyclonal BFP antiserum, although this blockage was incomplete and only reduced adhesion by around 50% (16). Mutants deficient in BFP production do not form localized colonies (7), although if the HEp-2 cell assay is continued for 6 h bacteria begin to adhere (7). Despite these data uncertainty still exists concerning whether BFP mediate the initial adhesion of EPEC to HEp-2 cells (15). The findings in this paper based on studies with IVOC support the original suggestion of Girón et al. (16) that "BFP participate in the formation of the bacterial colony by forming bundles that link one bacterium to another."
If BFP are not involved in initial adhesion then either intimin mediates initial and subsequent events or other adhesins await recognition. Gómez-Duarte and Kaper (18) showed that the addition of the cloned per region to JPN15 increased adherence and produced a poor localized adherence pattern; the increased adherence was specific for eae since inactivation of eae prevented the increased adhesion, indicating that intimin can promote adherence. Evidence has been put forward to suggest that the intimin receptor is the bacterial protein Tir (26) and that this protein must be transferred from bacillus to host and be phosphorylated to allow binding (26, 43). Adhesion of EPEC to the mucosa would be necessary for the efficient delivery of secreted molecules to the cell surface, and this necessity lends weight to the suggestion that further adhesins await discovery. However, no adhesion of intimin-deficient strains was seen in IVOC. It is possible that intimin-negative strains adhered so transiently that the time scale of these experiments missed the phenomenon or that the adhesion was so tenuous that washing prior to fixation removed the bacteria. These suggestions seem unlikely as only a few adhering bacteria were seen after 2 h in IVOC, CVD206 adheres well to HEp-2 cells over a similar time scale when identical growth and processing conditions are used, and colonization based on tenuous adhesion seems unlikely in vivo in the face of peristalsis and other nonspecific host defense mechanisms. Thus, the finding remains that intimin appears to be central to A/E lesion formation and EPEC colonization of pediatric intestinal mucosae. Possibly, additional intimin receptors await recognition. Future work is necessary to study the very early stages of EPEC adhesion to the mucosa and to investigate the suggested role of BFP in complex microcolony formation.
| |
ACKNOWLEDGMENTS |
|---|
We thank John Walker-Smith, Simon Murch, Mike Thomson, and David Casson (University Department of Paediatric Gastroenterology, Royal Free Hospital, London, United Kingdom) for providing intestinal biopsy tissue and Jorge Girón for providing anti-BFP antiserum.
J.B.K. is supported by grant AI21657 from the National Institutes of Health. G.D. is supported by a program grant from the Wellcome Trust.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University Department of Paediatric Gastroenterology, Royal Free Hospital, Pond St., London, NW3 2QG, United Kingdom. Phone: 171 8302783. Fax: 171 8302146. E-mail: adphill{at}rfhsm.ac.uk.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Baldini, M. M., J. B. Kaper, M. M. Levine, D. C. A. Candy, and H. W. Moon. 1983. Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 2:534-538[Medline]. |
| 2. | Bokete, T. N., T. S. Whittam, R. A. Wilson, C. R. Clausen, C. M. O'Callahan, S. L. Moseley, T. R. Fritsche, and P. I. Tarr. 1997. Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children. J. Infect. Dis. 175:1382-1389[Medline]. |
| 3. | Cravioto, A., R. J. Gross, S. M. Scotland, and B. Rowe. 1979. An adhesive factor found in strains of Escherichia coli belonging to traditional infantile enteropathogenic serotypes. Curr. Microbiol. 3:95-99. |
| 4. | Cravioto, A., A. Tello, A. Navarro, J. Ruiz, H. Villafán, F. Uribe, and C. Eslava. 1991. Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet 337:262-264[Medline]. |
| 5. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection vector.
Infect. Immun.
59:4310-4317 |
| 6. |
Donnenberg, M. S., and J. B. Kaper.
1992.
Enteropathogenic Escherichia coli.
Infect. Immun.
60:3953-3961 |
| 7. | Donnenberg, M. S., J. A. Girón, J. P. Nataro, and J. B. Kaper. 1992. A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localised adherence. Mol. Microbiol. 6:3427-3437[Medline]. |
| 8. | Donnenberg, M. S., C. O. Tacket, S. P. James, G. Losomsky, J. P. Nataro, S. S. Wasserman, J. B. Kaper, and M. M. Levine. 1993. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J. Clin. Invest. 92:1412-1417. |
| 9. | Echeverria, P., F. Orskov, I. Orskov, S. Knutton, F. Scheutz, J. E. Brown, and U. Lexomboon. 1991. Attaching and effacing enteropathogenic Escherichia coli as a cause of infantile diarrhoea in Bangkok. J. Infect. Dis. 164:550-554[Medline]. |
| 10. |
Foubister, V. I.,
I. Rosenshine,
M. S. Donnenberg, and B. B. Finlay.
1994.
The eaeB gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells.
Infect. Immun.
62:3038-3040 |
| 11. | Frankel, G., A. D. Phillips, M. Novakova, S. Hicks, and G. Dougan. Unpublished data. |
| 12. | Frankel, G., D. C. A. Candy, E. Fabiani, J. Adu-Bobie, S. Gil, M. Novakova, A. D. Phillips, and G. Dougan. 1995. Molecular characterization of a carboxy-terminal eukaryotic cell binding domain of intimin from enteropathogenic Escherichia coli. Infect. Immun. 63:4323-4328[Abstract]. |
| 13. | Frankel, G., A. D. Phillips, J. Adu-Bobie, D. C. A. Candy, G. Douce, and G. Dougan. 1996. Intimin adherence to epithelial cells. Rev. Microbiol. 27(Suppl. 1):99-103. |
| 14. |
Frey, A.,
K. T. Giannasca,
R. Weltzin,
P. J. Giannasca,
H. Reggio,
W. I. Lencer, and M. R. Neutra.
1996.
Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting.
J. Exp. Med.
184:1045-1059 |
| 15. | Girón, J. A. 1996. Fimbriae of enteropathogenic Escherichia coli. Rev. Microbiol. 27(Suppl. 1):72-76. |
| 16. |
Girón, J. A.,
A. S. Ho, and G. K. Schoolnik.
1991.
An inducible bundle-forming pilus of enteropathogenic Escherichia coli.
Science
254:710-713 |
| 17. | Gomes, T. A. T., M. A. M. Vieira, L. K. Wachsmuth, P. A. Blake, and L. R. Trabulsi. 1989. Serotype-specific prevalence of Escherichia coli strains with EPEC adherence factor genes in infants with and without diarrhoea in São Paulo, Brazil. J. Infect. Dis. 160:131-135[Medline]. |
| 18. | Gómez-Duarte, O. G., and J. B. Kaper. 1995. A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli. Infect. Immun. 63:1767-1776[Abstract]. |
| 19. | Goncalves, A. G., L. C. Campos, T. A. T. Gomes, J. Rodrigues, V. Sperandio, T. S. Whittam, and T. R. Trabulsi. 1997. Virulence properties and clonal structure of strains of Escherichia coli O119 serotypes. Infect. Immun. 65:2034-2040[Abstract]. |
| 20. | Hicks, S., D. C. A. Candy, and A. D. Phillips. 1996. Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect. Immun. 64:4751-4760[Abstract]. |
| 21. | Hicks, S., G. Frankel, G. Dougan, and A. D. Phillips. 1997. The role of BFP and intimin in enteropathogenic E. coli (EPEC) pathogenesis. J. Pediatr. Gastroenterol. Nutr. 24:468. |
| 22. |
Jarvis, K. G.,
J. A. Giron,
A. E. Jerse,
T. K. McDaniel,
M. S. Donnenberg, and J. B. Kaper.
1995.
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
Proc. Natl. Acad. Sci. USA
92:7996-8000 |
| 23. |
Jerse, A. E.,
J. Yu,
B. Tall, and J. B. Kaper.
1990.
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.
Proc. Natl. Acad. Sci. USA
87:7839-7843 |
| 24. |
Jerse, A. E., and J. B. Kaper.
1991.
The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid.
Infect. Immun.
59:4302-4309 |
| 25. | Kaper, J. B. 1996. Defining EPEC. Rev. Microbiol. 27(Suppl. 1):130-133. |
| 26. | Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B. Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520[Medline]. |
| 27. |
Kenny, B., and B. B. Finlay.
1995.
Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals in epithelial cells.
Proc. Natl. Acad. Sci. USA
92:7991-7995 |
| 28. |
Kilby, A.
1976.
Paediatric small intestinal biopsy capsule with two ports.
Gut
17:158-159 |
| 29. |
Knutton, S.,
M. M. Baldini,
J. B. Kaper, and A. S. McNeish.
1987.
Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells.
Infect. Immun.
55:78-85 |
| 30. |
Knutton, S.,
D. R. Lloyd, and A. S. McNeish.
1987.
Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa.
Infect. Immun.
55:69-77 |
| 31. |
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298 |
| 32. |
Knutton, S.,
M. M. McConnell,
B. Rowe, and A. S. McNeish.
1989.
Adhesion and ultrastructural properties of human enterotoxigenic Escherichia coli colonization factor antigens III and IV.
Infect. Immun.
57:3364-3371 |
| 33. |
Knutton, S.,
A. D. Phillips,
H. R. Smith,
R. J. Gross,
R. Shaw,
P. Watson, and E. Price.
1991.
Screening for enteropathogenic Escherichia coli in infants with diarrhea by the fluorescent-actin staining test.
Infect. Immun.
59:365-371 |
| 34. |
Knutton, S.,
R. K. Shaw,
M. K. Bhan,
H. R. Smith,
M. M. McConnell,
T. Cheasty,
P. H. Williams, and T. J. Baldwin.
1992.
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa.
Infect. Immun.
60:2083-2091 |
| 35. | Knutton, S., J. Adu-Bobie, C. Bain, A. D. Phillips, G. Dougan, and G. Frankel. 1997. Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion. Infect. Immun. 65:1644-1652[Abstract]. |
| 36. | Levine, M. M. 1987. Escherichia coli that cause diarrhoea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohaemorrhagic, and enteroadherent. J. Infect. Dis. 155:377-389[Medline]. |
| 37. | Levine, M. M., E. J. Berquist, D. R. Nalin, D. H. Waterman, R. B. Hornick, C. R. Young, S. Stoman, and B. Rowe. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet i:119-122. |
| 38. | Levine, M. M., V. Prado, R. Robins-Browne, H. Lior, J. B. Kaper, S. L. Moseley, K. Gicquelais, J. P. Nataro, P. Vial, and B. Tall. 1988. Use of DNA probes and HEp-2 cell adherence assay to detect diarrhoeagenic Escherichia coli. J. Infect. Dis. 158:224-228[Medline]. |
| 39. |
McDaniel, T.,
K. G. Jarvis,
M. S. Donnenberg, and J. B. Kaper.
1995.
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc. Natl. Acad. Sci. USA
92:1664-1668 |
| 40. | McDaniel, T. K., and J. B. Kaper. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399-407[Medline]. |
| 41. |
Moon, H. W.,
S. C. Whipp,
R. A. Argenzio,
M. M. Levine, and R. A. Gianella.
1983.
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.
Infect. Immun.
41:1340-1351 |
| 42. | Rosenshine, I., M. S. Donnenberg, J. B. Kaper, and B. B. Finlay. 1992. Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO J. 11:3551-3560[Medline]. |
| 43. | Rosenshine, I., S. Ruschkowski, M. Stein, D. J. Reinscheid, S. D. Mills, and B. B. Finlay. 1996. A pathogenic bacterium triggers epithelial signals to form a functional bacterial receptor that mediates pseudopod formation. EMBO J. 15:2613-2624[Medline]. |
| 44. | Rothbaum, R., A. J. McAdams, R. Giannella, and J. C. Partin. 1982. A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhoea in infants. Gastroenterology 83:441-454[Medline]. |
| 45. | Smith, H. R., S. M. Scotland, T. Cheasty, G. A. Willshaw, and B. Rowe. 1996. Enteropathogenic Escherichia coli infections in the United Kingdom. Rev. Microbiol. 27(Suppl. 1):45-49. |
| 46. |
Sohel, I.,
J. L. Puente,
S. W. Ramer,
D. Bieber,
C.-Y. Wu, and G. K. Schoolnik.
1996.
Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis.
J. Bacteriol.
178:2613-2628 |
| 47. | Stone, K. D., H.-Z. Zhang, L. K. Carlson, and M. S. Donnenberg. 1996. A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus. Mol. Microbiol. 20:325-337[Medline]. |
| 48. |
Ulshen, M. H., and J. L. Rollo.
1980.
Pathogenesis of Escherichia coli gastroenteritis in man another mechanism.
N. Engl. J. Med.
302:99-101[Medline].
|
| 49. | Viljanen, M. K., T. Peltola, S. Y. T. Junnila, L. Olkkonen, H. Jarvinen, M. Kustila, and P. Huovinen. 1990. Outbreak of diarrhoea due to Escherichia coli O111:B4 in school children and adults: association of Vi antigen-like reactivity. Lancet 336:831-834[Medline]. |
| 50. |
Vuopio-Varkila, J., and G. K. Schoolnik.
1991.
Localised adherence by enteropathogenic Escherichia coli is an inducible phenotype associated with the expression of new outer membrane proteins.
J. Exp. Med.
174:1167-1177 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||